AUF1 Regulation of R-Loop Resolution and Innate Immune Activation in DDR

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  iScience https://doi.org/10.1016/j.isci.2026.115900
Dr. Maria Carmen Ragosta et al.

Points

Researchers discovered that the RNA-binding protein AUF1 serves as a critical regulator at the intersection of genomic stability and the activation of the body’s innate immune response.
The downregulation of AUF1 leads to an accumulation of DNA-RNA hybrids called R-loops which are subsequently exported from the nucleus into the cytoplasm after significant DNA damage occurs.
Cytoplasmic R-loops activate the cGAS-STING signaling pathway to trigger the production of interferons and inflammatory molecules that are essential for effectively identifying and destroying abnormal cancer cells.
This study suggests that AUF1 could serve as a valuable therapeutic target for doctors looking to modulate the tumor microenvironment and improve the effectiveness of existing precision medicine.
Targeting the interconnected pathways of DNA repair and immune signaling represents a powerful new strategy for developing the next generation of highly effective and targeted cancer treatments.

Summary

This study investigated the role of the RNA-binding protein AUF1 as a critical regulator of genomic stability and innate immune signaling within the DNA Damage Response (DDR) framework. Researchers analyzed how the downregulation of AUF1 impairs homologous recombination, a primary pathway for double-strand break repair. The investigation focused on the accumulation of R-loops—complex DNA-RNA hybrids—which, when dysregulated, serve as potent endogenous stressors. The research sought to determine if these hybrids could bridge the gap between defective DNA repair and the modulation of the tumor microenvironment (TME).

The findings demonstrate that AUF1 depletion results in the massive accumulation and subsequent cytoplasmic export of R-loops following DNA damage. Once localized in the cytoplasm, these DNA-RNA hybrids function as a “non-self” molecular pattern, effectively activating the cGAS–STING (cyclic GMP-AMP synthase–stimulator of interferon genes) signaling pathway. This activation triggers a downstream inflammatory cascade, characterized by the production of Type I interferons and various cytokines essential for anti-tumor immunity. These results characterize AUF1 as a molecular switch that, when inhibited, can convert genomic instability into a detectable immune signal.

Anatomical and biochemical compatibility scans suggest that targeting AUF1 or directly modulating R-loop resolution could represent a viable therapeutic strategy to enhance the immunogenicity of “cold” tumors. By forcing the export of R-loops, clinicians may be able to stimulate a localized immune response specifically in cells with preexisting DDR defects. While current clinical data on specific hazard ratios for AUF1-low populations are still being aggregated, these results provide a mechanistic foundation for combining DDR inhibitors with immunotherapy. Precise therapeutic modulation of this pathway is critical to ensure tumor destruction while avoiding systemic hyper-inflammation.

Link to the article: https://www.cell.com/iscience/fulltext/S2589-0042(26)01275-7?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004226012757%3Fshowall%3Dtrue

References

Ragosta, M. C., Di Vaio, A., Cuomo, M., D’angelo, M., Medugno, A., Russo, A., Mazzarotti, G., Napolitano, G. M., Iannuzzi, C. A., Forte, I. M., Camerlingo, R., Martinelli, C., De Laurentiis, M., Giordano, A., & Alfano, L. (2026). The modulation of AUF1 regulates the R-loop resolution activating the immune response in DDR. iScience, 115900. https://doi.org/10.1016/j.isci.2026.115900